Specialty Retail
Compare Stocks
4 / 10Stock Comparison
DKS vs RGS vs ASO vs SKIN
Revenue, margins, valuation, and 5-year total return — side by side.
Personal Products & Services
Specialty Retail
Household & Personal Products
DKS vs RGS vs ASO vs SKIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Specialty Retail | Personal Products & Services | Specialty Retail | Household & Personal Products |
| Market Cap | $20.22B | $68M | $3.48B | $118M |
| Revenue (TTM) | $17.22B | $233M | $6.05B | $296M |
| Net Income (TTM) | $849M | $114M | $377M | $-6M |
| Gross Margin | 32.9% | 47.6% | 34.8% | 64.9% |
| Operating Margin | 7.7% | 10.5% | 8.5% | -3.6% |
| Forward P/E | 15.6x | 0.6x | 9.1x | — |
| Total Debt | $4.49B | $351M | $1.41B | $379M |
| Cash & Equiv. | $1.69B | $35M | $330M | $233M |
DKS vs RGS vs ASO vs SKIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| DICK'S Sporting Goo… (DKS) | 100 | 391.3 | +291.3% |
| Regis Corporation (RGS) | 100 | 16.5 | -83.5% |
| Academy Sports and … (ASO) | 100 | 325.5 | +225.5% |
| The Beauty Health C… (SKIN) | 100 | 9.0 | -91.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DKS vs RGS vs ASO vs SKIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DKS is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 11 yrs, beta 1.45, yield 2.2%
- Rev growth 28.1%, EPS growth -29.0%, 3Y rev CAGR 11.7%
- 450.0% 10Y total return vs ASO's 325.9%
- Lower volatility, beta 1.45, Low D/E 0.1%, current ratio 1530.03x
RGS carries the broadest edge in this set and is the clearest fit for value and quality.
- Better valuation composite
- 48.9% margin vs SKIN's -2.0%
- Beta 0.79 vs SKIN's 2.00, lower leverage
- +49.9% vs SKIN's -35.9%
ASO is the clearest fit if your priority is valuation efficiency.
- PEG 0.88 vs DKS's 1.32
SKIN lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 28.1% revenue growth vs SKIN's -10.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 48.9% margin vs SKIN's -2.0% | |
| Stability / Safety | Beta 0.79 vs SKIN's 2.00, lower leverage | |
| Dividends | 2.2% yield, 11-year raise streak, vs ASO's 1.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +49.9% vs SKIN's -35.9% | |
| Efficiency (ROA) | 19.4% ROA vs SKIN's -1.2%, ROIC 3.2% vs -6.8% |
DKS vs RGS vs ASO vs SKIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DKS vs RGS vs ASO vs SKIN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DKS leads in 2 of 6 categories
ASO leads 1 • RGS leads 0 • SKIN leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — DKS and RGS and SKIN each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DKS is the larger business by revenue, generating $17.2B annually — 73.7x RGS's $233M. RGS is the more profitable business, keeping 48.9% of every revenue dollar as net income compared to SKIN's -2.0%. On growth, DKS holds the edge at +59.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $17.2B | $233M | $6.1B | $296M |
| EBITDAEarnings before interest/tax | $1.4B | $29M | $635M | $9M |
| Net IncomeAfter-tax profit | $849M | $114M | $377M | -$6M |
| Free Cash FlowCash after capex | $399.7B | $15M | $264M | $29M |
| Gross MarginGross profit ÷ Revenue | +32.9% | +47.6% | +34.8% | +64.9% |
| Operating MarginEBIT ÷ Revenue | +7.7% | +10.5% | +8.5% | -3.6% |
| Net MarginNet income ÷ Revenue | +4.9% | +48.9% | +6.2% | -2.0% |
| FCF MarginFCF ÷ Revenue | +23.2% | +6.4% | +4.4% | +9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +59.9% | +22.3% | +2.5% | -6.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -61.0% | -94.1% | +8.2% | +38.0% |
Valuation Metrics
ASO leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 0.6x trailing earnings, RGS trades at a 97% valuation discount to DKS's 22.3x P/E. Adjusting for growth (PEG ratio), ASO offers better value at 0.94x vs DKS's 1.90x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $20.2B | $68M | $3.5B | $118M |
| Enterprise ValueMkt cap + debt − cash | $23.0B | $384M | $4.6B | $264M |
| Trailing P/EPrice ÷ TTM EPS | 22.29x | 0.64x | 9.67x | -5.69x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.56x | — | 9.11x | — |
| PEG RatioP/E ÷ EPS growth rate | 1.90x | — | 0.94x | — |
| EV / EBITDAEnterprise value multiple | 12.66x | 16.75x | 7.18x | 7331.15x |
| Price / SalesMarket cap ÷ Revenue | 1.17x | 0.32x | 0.57x | 0.39x |
| Price / BookPrice ÷ Book value/share | 0.00x | 0.40x | 1.68x | 2.02x |
| Price / FCFMarket cap ÷ FCF | 0.05x | 5.48x | 15.66x | 3.17x |
Profitability & Efficiency
Evenly matched — RGS and ASO each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
RGS delivers a 60.4% return on equity — every $100 of shareholder capital generates $60 in annual profit, vs $-9 for SKIN. DKS carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to SKIN's 6.20x. On the Piotroski fundamental quality scale (0–9), ASO scores 7/9 vs DKS's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +0.1% | +60.4% | +18.1% | -9.4% |
| ROA (TTM)Return on assets | +6.1% | +19.4% | +7.1% | -1.2% |
| ROICReturn on invested capital | +0.0% | +3.2% | +11.4% | -6.8% |
| ROCEReturn on capital employed | +0.0% | +3.9% | +12.5% | -4.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.00x | 1.89x | 0.65x | 6.20x |
| Net DebtTotal debt minus cash | $2.8B | $316M | $1.1B | $146M |
| Cash & Equiv.Liquid assets | $1.7B | $35M | $330M | $233M |
| Total DebtShort + long-term debt | $4.5B | $351M | $1.4B | $379M |
| Interest CoverageEBIT ÷ Interest expense | 19.04x | 1.31x | 14.33x | 0.81x |
Total Returns (Dividends Reinvested)
DKS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DKS five years ago would be worth $27,378 today (with dividends reinvested), compared to $707 for SKIN. Over the past 12 months, RGS leads with a +49.9% total return vs SKIN's -35.9%. The 3-year compound annual growth rate (CAGR) favors DKS at 18.7% vs SKIN's -56.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +11.6% | +4.7% | +3.0% | -35.0% |
| 1-Year ReturnPast 12 months | +20.6% | +49.9% | +39.1% | -35.9% |
| 3-Year ReturnCumulative with dividends | +67.2% | +35.9% | -9.4% | -91.7% |
| 5-Year ReturnCumulative with dividends | +173.8% | -85.5% | +63.6% | -92.9% |
| 10-Year ReturnCumulative with dividends | +450.0% | -89.7% | +325.9% | -91.6% |
| CAGR (3Y)Annualised 3-year return | +18.7% | +10.8% | -3.2% | -56.4% |
Risk & Volatility
Evenly matched — DKS and RGS each lead in 1 of 2 comparable metrics.
Risk & Volatility
RGS is the less volatile stock with a 0.79 beta — it tends to amplify market swings less than SKIN's 2.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DKS currently trades 93.7% from its 52-week high vs SKIN's 33.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.45x | 0.79x | 1.72x | 2.00x |
| 52-Week HighHighest price in past year | $237.31 | $31.50 | $62.45 | $2.69 |
| 52-Week LowLowest price in past year | $167.03 | $17.50 | $37.96 | $0.76 |
| % of 52W HighCurrent price vs 52-week peak | +93.7% | +88.9% | +85.7% | +33.8% |
| RSI (14)Momentum oscillator 0–100 | 59.0 | 56.3 | 46.2 | 52.1 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 9K | 1.4M | 760K |
Analyst Outlook
DKS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DKS as "Buy", ASO as "Buy", SKIN as "Hold". Consensus price targets imply 42.9% upside for SKIN (target: $1) vs 8.3% for ASO (target: $58). For income investors, DKS offers the higher dividend yield at 2.19% vs ASO's 0.95%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy | Hold |
| Price TargetConsensus 12-month target | $251.43 | — | $58.00 | $1.30 |
| # AnalystsCovering analysts | 63 | — | 22 | 13 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | — | +1.0% | — |
| Dividend StreakConsecutive years of raises | 11 | 0 | 3 | — |
| Dividend / ShareAnnual DPS | $4.86 | — | $0.51 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.7% | 0.0% | +5.7% | 0.0% |
DKS leads in 2 of 6 categories (Total Returns, Analyst Outlook). ASO leads in 1 (Valuation Metrics). 3 tied.
DKS vs RGS vs ASO vs SKIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DKS or RGS or ASO or SKIN a better buy right now?
For growth investors, DICK'S Sporting Goods, Inc.
(DKS) is the stronger pick with 28. 1% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). Regis Corporation (RGS) offers the better valuation at 0. 6x trailing P/E, making it the more compelling value choice. Analysts rate DICK'S Sporting Goods, Inc. (DKS) a "Buy" — based on 63 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DKS or RGS or ASO or SKIN?
On trailing P/E, Regis Corporation (RGS) is the cheapest at 0.
6x versus DICK'S Sporting Goods, Inc. at 22. 3x. On forward P/E, Academy Sports and Outdoors, Inc. is actually cheaper at 9. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Academy Sports and Outdoors, Inc. wins at 0. 88x versus DICK'S Sporting Goods, Inc. 's 1. 32x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DKS or RGS or ASO or SKIN?
Over the past 5 years, DICK'S Sporting Goods, Inc.
(DKS) delivered a total return of +173. 8%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: DKS returned +450. 0% versus SKIN's -91. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DKS or RGS or ASO or SKIN?
By beta (market sensitivity over 5 years), Regis Corporation (RGS) is the lower-risk stock at 0.
79β versus The Beauty Health Company's 2. 00β — meaning SKIN is approximately 154% more volatile than RGS relative to the S&P 500. On balance sheet safety, DICK'S Sporting Goods, Inc. (DKS) carries a lower debt/equity ratio of 0% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.
05Which is growing faster — DKS or RGS or ASO or SKIN?
By revenue growth (latest reported year), DICK'S Sporting Goods, Inc.
(DKS) is pulling ahead at 28. 1% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to -29. 0% for DICK'S Sporting Goods, Inc.. Over a 3-year CAGR, DKS leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DKS or RGS or ASO or SKIN?
DICK'S Sporting Goods, Inc.
(DKS) is the more profitable company, earning 49. 3% net margin versus -3. 2% for The Beauty Health Company — meaning it keeps 49. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RGS leads at 9. 5% versus -6. 9% for SKIN. At the gross margin level — before operating expenses — SKIN leads at 65. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DKS or RGS or ASO or SKIN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Academy Sports and Outdoors, Inc. (ASO) is the more undervalued stock at a PEG of 0. 88x versus DICK'S Sporting Goods, Inc. 's 1. 32x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Academy Sports and Outdoors, Inc. (ASO) trades at 9. 1x forward P/E versus 15. 6x for DICK'S Sporting Goods, Inc. — 6. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SKIN: 42. 9% to $1. 30.
08Which pays a better dividend — DKS or RGS or ASO or SKIN?
In this comparison, DKS (2.
2% yield), ASO (1. 0% yield) pay a dividend. RGS, SKIN do not pay a meaningful dividend and should not be held primarily for income.
09Is DKS or RGS or ASO or SKIN better for a retirement portfolio?
For long-horizon retirement investors, DICK'S Sporting Goods, Inc.
(DKS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (2. 2% yield, +450. 0% 10Y return). The Beauty Health Company (SKIN) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DKS: +450. 0%, SKIN: -91. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DKS and RGS and ASO and SKIN?
These companies operate in different sectors (DKS (Consumer Cyclical) and RGS (Consumer Cyclical) and ASO (Consumer Cyclical) and SKIN (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DKS is a mid-cap high-growth stock; RGS is a small-cap deep-value stock; ASO is a small-cap deep-value stock; SKIN is a small-cap quality compounder stock. DKS, ASO pay a dividend while RGS, SKIN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.